Acerus Pharmaceuticals Corporation

Acerus Pharmaceuticals Corporationverified

ASP.TO

Price:

$0.36

Market Cap:

$2.02M

Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; and Noctiva, a vasopressin analog indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Tefina,...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2009-09-03

Stock Exchange

TSX

Ticker

ASP.TO

The PE Ratio as of December 2025 (TTM) for Acerus Pharmaceuticals Corporation (ASP.TO) is -0.08

According to Acerus Pharmaceuticals Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.08. This represents a change of 19.54% compared to the average of -0.07 of the last 4 quarters.

Acerus Pharmaceuticals Corporation (ASP.TO) Historical PE Ratio (quarterly & annually)

How has ASP.TO PE Ratio performed in the past?

The mean historical PE Ratio of Acerus Pharmaceuticals Corporation over the last ten years is -0.02. The current -0.08 PE Ratio has changed 41.86% with respect to the historical average. Over the past ten years (40 quarters), ASP.TO's PE Ratio was at its highest in in the September 2015 quarter at 0.07. The PE Ratio was at its lowest in in the March 2015 quarter at -2.15.

Quarterly (TTM)
Annual

Average

-0.02

Median

-0.02

Minimum

-0.06

Maximum

0.03

Acerus Pharmaceuticals Corporation (ASP.TO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Acerus Pharmaceuticals Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 264.69%

Maximum Annual PE Ratio = 0.03

Minimum Annual Increase = -239.33%

Minimum Annual PE Ratio = -0.06

Quarterly (TTM)
Annual
YearPE RatioChange
2021-0.06264.69%
2020-0.02-32.64%
2019-0.0338.95%
2018-0.02-55.06%
2017-0.04-239.33%
20160.03-187.05%
2015-0.03139.74%
2014-0.0174.63%
2013-0.0123.20%
2012-0.0125.21%

Acerus Pharmaceuticals Corporation (ASP.TO) Average PE Ratio

How has ASP.TO PE Ratio performed in the past?

The current PE Ratio of Acerus Pharmaceuticals Corporation (ASP.TO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-0.03

5-year avg

-0.03

10-year avg

-0.02

Acerus Pharmaceuticals Corporation (ASP.TO) PE Ratio vs. Peers

How is ASP.TO’s PE Ratio compared to its peers?

Acerus Pharmaceuticals Corporation’s PE Ratio is less than ManifestSeven Holdings Corporation (-0.00), less than Craftport Cannabis Corp. (-0.00), less than Radient Technologies Inc. (0), less than Flower One Holdings Inc. (-0.00), less than Choom Holdings Inc. (-0.00), greater than AREV Life Sciences Global Corp. (-1.87), greater than Isracann Biosciences Inc. (-0.47), greater than Aion Therapeutic Inc. (-1.99), greater than Revitalist Lifestyle and Wellness Ltd. (-0.10), less than North Bud Farms Inc. (-0.00),

Build a custom stock screener for Acerus Pharmaceuticals Corporation (ASP.TO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acerus Pharmaceuticals Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acerus Pharmaceuticals Corporation (ASP.TO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acerus Pharmaceuticals Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Acerus Pharmaceuticals Corporation's PE Ratio?

How is the PE Ratio calculated for Acerus Pharmaceuticals Corporation (ASP.TO)?

What is the highest PE Ratio for Acerus Pharmaceuticals Corporation (ASP.TO)?

What is the 3-year average PE Ratio for Acerus Pharmaceuticals Corporation (ASP.TO)?

What is the 5-year average PE Ratio for Acerus Pharmaceuticals Corporation (ASP.TO)?

How does the current PE Ratio for Acerus Pharmaceuticals Corporation (ASP.TO) compare to its historical average?